India provides world-class, affordable treatment for Multiple Myeloma and Plasma Cell Neoplasms, including chemotherapy, targeted therapy, and stem cell transplant. Total treatment costs in India range from $7,000 – $25,000, depending on the stage and treatment plan. In contrast, the same procedures can cost $60,000 – $120,000 in the USA and $20,000 – $40,000 in Thailand, making India a top destination for comprehensive and budget-friendly cancer care.
Multiple Myeloma is a cancer of plasma cells, which are white blood cells responsible for producing antibodies. It is part of a group of disorders called Plasma Cell Neoplasms, which also includes Monoclonal Gammopathy of Undetermined Significance (MGUS) and Plasmacytoma. These cancers accumulate in the bone marrow and interfere with normal blood cell production, leading to anemia, bone pain, frequent infections, kidney dysfunction, and high calcium levels. Over time, these malignant plasma cells produce abnormal proteins that can damage various organs.
The exact cause of Multiple Myeloma is not fully understood, but it is believed to involve a combination of genetic, environmental, and immune-related factors. Common risk factors include:
Types:
Staging (International Staging System - ISS):
India has become a global medical hub due to:
Dr. Ankur Bahl is a senior consultant medical oncologist known for his leadership in treating hematologic malignancies. Reasons to choose Dr. Bahl include:
Induction Therapy (First Line Treatment):
Duration: 4–6 cycles before transplant.
Stem Cell Transplantation (ASCT):
Targeted Therapy:
Immunomodulatory Agents (IMiDs):
Maintenance Therapy:
Relapsed Myeloma Therapy:
|
Treatment Component |
Estimated Cost (USD) |
|
Diagnostic Tests (CBC, Biopsy, Imaging) |
$800 – $1,500 |
|
Chemotherapy (Per Cycle) |
$600 – $1,200 |
|
Targeted Drugs (e.g., Bortezomib) |
$2,000 – $4,000/month |
|
Stem Cell Transplant (ASCT) |
$12,000 – $18,000 |
|
Maintenance Therapy (Lenalidomide/year) |
$2,000 – $4,000 |
|
Supportive Medications & Hospital Stay |
$1,000 – $2,000 |
|
Total Estimated Cost |
$7,000 – $25,000 |
|
Country |
Total Cost Estimate (USD) |
|
India |
$7,000 – $25,000 |
|
USA |
$60,000 – $120,000 |
|
Thailand |
$20,000 – $40,000 |
|
UK |
$50,000 – $100,000 |
Conclusion India is an excellent destination for international patients seeking Multiple Myeloma treatment at a fraction of the Western cost. With expert guidance from renowned oncologists like Dr. Ankur Bahl, high-end infrastructure, and personalized care, foreign patients can expect cutting-edge therapy, safe stem cell transplants, and long-term disease control in a compassionate and globally recognized setting
Multiple Myeloma is considered a chronic but treatable cancer. While it may not be curable in most cases, patients can achieve long-term remission with a combination of chemotherapy, stem cell transplant, and maintenance therapy. Ongoing research is advancing new therapies that continue to improve outcomes.
You can typically begin treatment within 5 to 7 days of arrival. Initial diagnostic tests are quickly arranged, and teleconsultations before travel allow hospitals to pre-plan your care for a smoother experience.
Yes, India has internationally accredited transplant centers with world-class HEPA-filtered transplant units and infection control protocols. Thousands of successful ASCT procedures are performed every year with excellent outcomes.
Absolutely. India uses globally approved drugs, including those by top pharmaceutical brands. Many medications are the same FDA-approved agents used worldwide, and quality standards are rigorously maintained.
After treatment, you will receive detailed discharge summaries, follow-up plans, and the option for virtual consultations. Hospitals offer email and video follow-ups for ongoing care once you return home.
Yes. Many Indian oncologists have trained or worked in top institutions in the USA, UK, or Europe. They follow NCCN and ESMO guidelines and are experienced in using the latest therapeutic agents and technologies.
Definitely. You can email your medical reports, including pathology and imaging, to get a second opinion before deciding on travel. A personalized treatment plan and approximate cost estimate will be shared with you.